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Abstract
Background: A new tool to assess Risk of Bias In Non-randomised Studies of Interventions (ROBINS-I) was
published in Autumn 2016. ROBINS-I uses the Cochrane-approved risk of bias (RoB) approach and focusses on
internal validity. As such, ROBINS-I represents an important development for those conducting systematic reviews
which include non-randomised studies (NRS), including public health researchers. We aimed to establish the
applicability of ROBINS-I using a group of NRS which have evaluated non-clinical public health natural experiments.
Methods: Five researchers, all experienced in critical appraisal of non-randomised studies, used ROBINS-I to independently
assess risk of bias in five studies which had assessed the health impacts of a domestic energy efficiency intervention.
ROBINS-I assessments for each study were entered into a database and checked for consensus across the group. Group
discussions were used to identify reasons underpinning lack of consensus for specific questions and bias domains.
Results: ROBINS-I helped to systematically articulate sources of bias in NRS. However, the lack of consensus in assessments
for all seven bias domains raised questions about ROBINS-I’s reliability and applicability for natural experiment studies. The
two RoB domains with least consensus were selection (Domain 2) and performance (Domain 4). Underlying the lack of
consensus were difficulties in applying an intention to treat or per protocol effect of interest to the studies. This was linked to
difficulties in determining whether the intervention status was classified retrospectively at follow-up, i.e. post hoc. The
overall risk of bias ranged from moderate to critical; this was most closely linked to the assessment of confounders.
Conclusion: The ROBINS-I tool is a conceptually rigorous tool which focusses on risk of bias due to the counterfactual.
Difficulties in applying ROBINS-I may be due to poor design and reporting of evaluations of natural experiments. While
the quality of reporting may improve in the future, improved guidance on applying ROBINS-I is needed to enable existing
evidence from natural experiments to be assessed appropriately and consistently. We hope future refinements to ROBINS-I
will address some of the issues raised here to allow wider use of the tool.
Keywords: Non-randomised studies, Controlled before and after, Natural experiments, Public health, Risk of bias,
Methodological quality
Background
Well-conducted randomised controlled trial (RCT) may
be considered to provide the most robust type of evi-
dence for questions of effectiveness. When rigorously
implemented, the use of randomisation minimises key
sources of bias due to confounding and selection. Con-
sequently, randomisation provides effect estimates which
are less susceptible to bias compared to those reported
in non-randomised studies (NRS) [1]. However, for
many important questions—for example in public
health, public policy, and health services research—RCTs
are not available or feasible and the best available evi-
dence may come from NRS [2]. Before attempting to use
or apply research evidence, it is critical to make an in-
formed assessment about its validity or reliability. All re-
search is susceptible to bias, and any conclusions or
lessons should be considered in light of any identified
bias or limitations [3]. This is the case whether drawing
from a single study or synthesising a body of evidence,
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for example conducting a systematic review, and also
whether or not the evidence is from RCTs or NRSs.
There are many tools available to assess study quality, [4]
many of which focus on methodological quality and poten-
tially conflate issues of internal and external validity which
is problematic. Over the past few years, there has been a
shift to focus on risk of bias. This approach focusses on
internal validity, and specific bias domains are considered
in turn [5]. In 2011, the Cochrane Risk of Bias (RoB) tool
(now updated to RoB v2.0) [6] for RCTs using this domain-
based approach was published by the Cochrane Statistical
Methods Group and the Cochrane Bias Methods Group.
Bias domains included in RoB v2.0 are randomisation,
deviation from intended interventions, missing data,
measurement of outcomes, and selection of reported result.
The Cochrane RoB tool is the preferred assessment method
for any RCT included in a Cochrane review, but the tool is
not designed to assess RoB for NRS. In October 2016, a
new tool to assess RoB in NRS was published: Risk of Bias
In Non-randomised Studies of Interventions (ROBINS-I)
[5]. This tool was developed by the Cochrane Bias Methods
Group, informed by input from a wide international group
of leading epidemiologists and methodologists. Publication
of this tool represents a potentially substantial improve-
ment in how NRS can be incorporated into well-conducted
systematic reviews of interventions; publication of
ROBINS-I has been eagerly anticipated by those working
in areas where NRS are commonly included in reviews,
such as public health. Like RoB v2.0, ROBINS-I focusses
on assessing internal validity, assessing seven specific bias
domains. Signalling questions (SQs) are provided to help
assessors decide the overall assessment for each bias do-
main. In ROBINS-I, bias is defined as a systematic differ-
ence between the results of the NRS and the results
expected from a hypothetical target trial which is unre-
stricted by practical or ethical issues. The rationale for this
is that the NRS is attempting to emulate an RCT, and the
comparison of the NRS with a hypothetical target trial al-
lows an assessment of the bias in the NRS data relative to a
hypothetical RCT addressing the same question. More de-
tail of what the ROBINS-I assessment process involves and
the bias domains is provided in Table 1.
As indicated in the ROBINS-I publication, previous ver-
sions of the tool have been piloted over its development
period. Much of this work has given rise to questions,
formally and informally, around the usability of the tool, as
well as issues of application to non-clinical topic areas and
inter-rater reliability [7–10]. This paper reports the find-
ings of a group of public health researchers experienced in
critical appraisal of NRS in applying the ROBINS-I tool to
studies of non-clinical public health interventions. Specific-
ally, the studies assessed the health impacts of housing
improvement and were previously included in a Cochrane
systematic review led by HT [11]. The aim of this work
was twofold: (1) to establish ease of use in applying the tool
beyond the clinical realm and (2) through informal consen-
sus methods, identify and articulate issues in application of
the tool, specifically when applied to studies evaluating the
health effects of natural experiments.
Methods
A group of five public health researchers was convened to
use and test the ROBINS-I tool. The level of experience in
conducting critical appraisal of NRS ranged from moderate
to extensive. All NRS of warmth and energy efficiency im-
provements [12–16] included in a Cochrane review [11, 17]
were selected to be assessed using ROBINS-I. In the original
Cochrane review, the studies had been assessed using two
tools: The Effective Public Health and Practice Project
(EPHPP) [18] tool recommended by Cochrane Public
Health (CPH) [19] to assess NRS and the Cochrane RoB
tool (version 1.0). In the original review, the Cochrane Ef-
fective Practice and Organisation of Care (EPOC) questions
on confounding were included in the assessment, and two
further items (baseline response and blinding of analysts)
Table 1 Summary of ROBINS-I tool
Review protocol level considerations
Specify aspects of review question: Population, Intervention,
Comparator, Outcome (PICO).
Outline how complexities in the PICO will be accommodated in the review.
Confounders: the review protocol should pre-specify relevant confounders
which are related to exposure to the intervention.
Co-interventions: the review protocol should state interventions or
exposures which are related to the intervention and prognostic for the
outcome of interest.
Study level considerations (to be assessed for each study)
Target trial (TT): define key characteristics (eligibility of participants, intervention,
comparator, outcome, effect of interest (see below)) of a hypothetical RCT (this
should not be limited by pragmatic or ethical concerns).
Effect of interest (EoI): per protocol (PP—starting and adhering to
intervention as outlined in intervention protocol) OR intention to treat
(ITT—assignment to receive intervention regardless of subsequent
exposure or adherence)
Bias domains
Pre-intervention
Domain 1: confounding
Domain 2: selection of participants into the study
At intervention
Domain 3: classification of interventions
Post-intervention
Domain 4: deviation from intended interventions*
Domain 5: missing data*
Domain 6: measurement of outcomes*
Domain 7: selection of reported result*
* Domain also part of RoB version 2.0 for RCTs
Assessment options for each signalling question (SQ): Yes, Probably
Yes, Probably No, No, No Information.
Domain level RoB assessment options: Low, Moderate, Serious,
Critical, No information.
Overall assessment (by outcome): Low, Moderate, Serious, Critical.
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were incorporated into the Cochrane RoB tool (version 1.0),
to reflect the domains used in the EPHPP tool.
Each member of the group read the ROBINS-I guid-
ance [20] and independently identified queries for wider
discussion. The group met to discuss preliminary queries
raised, agree to the selected studies to be assessed, and
agree to the protocol level considerations.
One study was assessed by each member of the group
to identify further areas in need of clarification; developers
of ROBINS-I were contacted for clarification on definition
of selection bias (Domain 2) before the remaining studies
were assessed. All studies were assessed independently by
each member of the group. Assessments were entered into
a Microsoft Access© database. Assessments for each of
the studies were examined by HT for variations by asses-
sor, and three meetings of the assessors were necessary to
further discuss and clarify varying interpretations of the
questions. Points of common understanding and clarifica-
tion were recorded and shared with the group to promote
consistent assessments across the group. This supplemen-
tary guidance document was edited and added throughout
the project (Appendix 1).
Finally, we compared the ROBINS-I assessments with
the EPHPP and Cochrane RoB (version 1.0) tool assess-
ments from the original review (Appendix 2).
Results
Of the five studies for assessment, four had a comparison
group and one did not. Each of the studies reported out-
come measures before exposure to the intervention and at
a follow-up period, ranging between 3 months and 3 years,
after initial receipt of the intervention. The four studies with
a comparison or control group were categorised as having a
controlled before and after study design. The following
sections describe the protocol level considerations, includ-
ing the study specific target trials and the RoB assessments
for each domain. We report a summary of the discussions
within the group and reasons for unresolved consensus
around the target trial characteristics and RoB assessments.
Protocol level considerations
The details of the review question and Population, Interven-
tion, Comparator, and Outcome (PICO) for the review were
agreed and are summarised in Table 2. The review PICO was
broadly defined reflecting the broad review question (What
are the health impacts of warmth and energy efficiency mea-
sures?). The outcome selected for assessment was “respiratory
health” and included ascertainment by self or parent reported
measures. After some discussion, it was agreed that there
were no identifiable co-interventions associated with the
intervention. Co-interventions are those “that individuals
might receive”, are “not part of intended intervention”, but
are “related to the intervention...and which are prognostic for
the outcome of interest” [20]. Disruption experienced during
installation of the warmth and energy efficiency measures
was considered a possible co-intervention. However, as some
disruption is an inevitable part of home improvement, it was
agreed that disruption did not meet the required definition of
a co-intervention. Relevant key confounding domains consid-
ered were baseline health outcome status, housing quality,
socio-economic status, and eligibility for intervention. It was
agreed that the review question was about the effects of hous-
ing improvements as they are delivered in usual practice.
Therefore, the EoI was intention to treat (ITT).
Study specific target trial (TT)
Characteristics of the target trials are presented in Table 2.
The broad definition of the review question in the protocol
meant that, while all studies met the scope and key charac-
teristics of the review, the characteristics of the target trials
(TT) were far more specific and highlighted issues of
heterogeneity across the study data to be synthesised.
Across the five studies, 18 different measures of respiratory
health were reported. It was agreed to select a single
respiratory outcome for the review protocol to allow agree-
ment with the outcome in the study specific TT; the out-
come selected was wheeze. For each TT, the outcome most
closely linked to “wheeze” was selected following group
discussion. The comparisons in the TTs were those who
did not receive the intervention but who were otherwise
eligible for the intervention. In the actual studies, the com-
parison group were those who did not receive the interven-
tion, either through self-selection or failure to meet
eligibility criteria, from the named provider specified by
the research authors. Although it was possible that individ-
uals received the intervention through other channels as
the intervention of interest, warmth improvement is widely
available. In the studies, the comparison group, therefore,
represented the equivalent of usual care.
Effect of interest in target trial and post hoc classification
of intervention status
The group of assessors was unable to reach consensus
about the EoI assessed in four of the included studies.
This was largely because in some studies, it was not
clear whether the intervention status (i.e. whether a par-
ticipant was in the intervention or control group) of the
study participants was known at baseline or whether
intervention status was ascertained at follow-up. This
fuelled much discussion about whether or not the con-
cept of ITT or per protocol effects of interest could be
applied when the intervention status was classified retro-
spectively by the research team (i.e. at follow-up, here-
after referred to as post hoc classification) rather than at
the baseline period and prior to or at the point of deliv-
ery of the intervention (see also the “Domain 3” section
below for elaboration about classification of intervention
status in ROBINS-I).
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Level of agreement and reasons for lack of agreement in
RoB domain assessments
The range of assessed RoB for each study and by domain is
presented in Table 3. There was variation across the assess-
ments for each study: this did not appear to be related to par-
ticular assessors. Discussions between assessors to clarify
common understandings of the signalling questions helped
to improve agreement between assessors. However, even as-
sessors with considerable experience in critical appraisal of
NRS expressed a lack of confidence in their final assessments.
The following section summarises the extent of agreement
for each bias domain and where possible identifies explana-
tions for the lack of agreement between reviewers. A sum-
mary of key outstanding queries is provided in Table 4.
Domain 1: confounding
Confounding variables considered to be relevant at the
protocol level were assessed as critical. If the critical
confounders were not taken into account through study
design or analysis, this resulted in a “critical risk of bias”
assessment due to confounding. Additional confounders
for individual studies were considered to be critical where
there was clear justification in the paper.
Most assessments for Domain 1 were within one de-
gree of each other. The variation in assessments was
largely explained by differences in assessors’ interpreta-
tions of the potential for bias from identified con-
founders and adequacy of adjustment for confounders.
Domain 2: selection of participants into the study
Domain 2, together with Domain 4, had a high level of
variance between assessors which was not fully resolved
through discussion. Confusion about what “selection into
the study” (Q2.1) meant led to a query to the developers of
the ROBINS-I tool. Following this, guidance was developed
to promote consistent assessments, and an alternative
signalling question (SQ) for SQ2.1 was provided
(Appendix 1). The distinction between prevalent and
incident exposure was emphasised to assessors, and it was
highlighted that differences in eligibility and inclusion in the
analysis was the issue of interest rather than selective inclu-
sion for the intervention, study, or dataset. However, discus-
sion about selection for the intervention, the study, and the
analysis were not completely resolved. In addition, it was
not always clear from the study report whether or not selec-
tion for the intervention and classification of intervention
status, the study, and/or the analysis was post hoc (Table 2,
see Braubach et al. [12]). The variations in assessment also
drew attention to differences in assessors’ interpretation of
the level at which the intervention was being assessed:
delivery of the programme at an area level, delivery of the
intervention to households, or implementation and adher-
ence to the intervention by householders (see Table 5).
Assessors queried the distinction between SQ2.2 and
SQ2.3, which asks whether the post-intervention variables
that influenced selection were likely to be associated with
receipt of the intervention (SQ2.2) or likely to be influenced
by the outcome or a cause of the outcome (SQ2.3). For in-
terventions that address socio-economic determinants of
health, and where the evaluation allows for post hoc classi-
fication of intervention or control status, it is highly likely
that selection into the intervention group may be influ-
enced or even determined by health status (e.g. investing in
warmth improvements amongst people who have a house-
hold member with asthma) or causes of health status (such
as income or other measures of socio-economic
deprivation). There is a further risk of selection bias as the
studies or evaluations were conducted on discrete popula-
tions likely to be offered the intervention. It is therefore
possible that participation in the survey or study could be
perceived by potential participants to be associated with re-
ceipt of the intervention, and/or health status may have in-
fluenced participation; hence, the sample analysed within
the study may provide misleading estimates of the EoI.
Table 3 Range of overall assessments by study and bias domains
Domain 1:
confounding
Domain
2: selection
Domain 3:
classification
of intervention
Domain 4:
deviation from
interventions
Domain
5: missing
data
Domain 6:
measurement
of outcomes
Domain
7: selection of
reported result
ROBINS-I
overall
Cochrane
risk of bias
(version1)
EPHPP
Braubach
[12]
3–4 (0) 3–4 Ŧ 1 1–4 2–3 2–3 2 3–4 Serious–
Critical
Critical Low
Hopton
[14]
2–4 1–4 1–2 1–3 3 2–3 2 2–4 Moderate–
Critical
Critical Moderate
Shortt
[13]
3–4 3–4 1–2 2–3 2–3 (0) 2–3Ŧ 2–3 3–4 Serious–
Critical
Critical Moderate
Somerville
[15]
4 3–4 1 1–2 2–3 3 2 4 Critical Critical Moderate
Walker
[16]
2–3 1–4 1–2 1–2 (0) 2–3Ŧ 1–3 2–3 2–3 Moderate–
Serious
Critical Low
Risk of bias assessment: 0 No information; 1 Low; 2 Moderate; 3 Serious; 4 Critical
Bold figures indicate disagreement of two or more levels of bias across assessments
Ŧ0 (no information) was assessed as equivalent to “Serious” (3) indicating agreement within one level of bias for each domain where “0” was used by
one or more assessor
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Each of the studies were conducted prospectively and
assessed the effect of incident exposure. Baseline assess-
ment of the outcome was made before the participants re-
ceived the intervention and then at follow-up between
3 months to 3.5 years after the intervention. Assessors
were not in agreement about whether this meant that the
start of the intervention and start of follow-up coincided
(SQ 2.4) and whether SQ2.4 could be applied when time-
to-event (survival) analysis was not being used. The
ROBINS-I guidance refers to time-to-event outcomes that
are typically assessed using survival analysis (e.g. death, in-
cident disease, etc.), but in our studies, the outcomes were
assessed using repeated measures (e.g. asthma symptoms)
on a panel or cohort of participants.
In most studies, the lengths of exposure to the intervention
at follow-up varied within the study sample. In one study, the
variation was over 2 years. Some assessors raised this as intro-
ducing selection bias as well as being related to assessments
about the start of intervention coinciding with follow-up.
However, following discussion, it was agreed not to treat this
as a component of selection bias. There was further discus-
sion about whether the least possible RoB for this domain
for studies with no control group would be “Serious”.
Domain 3: classification of interventions
Domain 3 had the greatest level of agreement, with all as-
sessments within one degree of each other. Based on the
ROBINS-I guidance, our assessments focussed more on dif-
ferential misclassification of interventions than the timing of
recording intervention status. The guidance on misclassifica-
tion of interventions emphasises potential bias due to recall
bias or retrospective identification of eligible participants.
The issue of post hoc classification of intervention status is
likely to be an important consideration of this domain; this
could be clearer in the guidance and signalling questions.
Domain 4: deviations from intended interventions
There was a high level of variance in assessments across
assessors for Domain 4. The different assessments arose
mainly for the following reasons: confusion about the EoI;
how to assess studies where the intervention status was
classified at follow-up; post hoc classification; and a lack of
clarity about the meaning and appropriate application of
key concepts for this domain, such as implementation or
adherence, co-interventions, contamination and blinding.
There was confusion about whether the question lead-
ing into SQs 4.2–4.4 (if your aim for this study is to as-
sess the effect of initiating and adhering to the
intervention (as in a per protocol analysis)) related to
the aim for the review and the characteristics of the re-
view outlined at the “protocol considerations” stage (see
above) or the type of analysis which had been used in
the study being assessed. This also raised questions
about whether analyses based on post hoc intervention
classification could be described as ITT or per protocol.
There was uncertainty among assessors about what
was meant by successful implementation (SQ 4.1), and
the level at which implementation failure (SQ 4.1) and
Table 4 Summary of outstanding queries for Domain 2 and 4 of ROBINS-I tool
Domain 2: selection of participants into the study
• Further guidance on the distinction between SQ2.2 and SQ2.3, (“Were the post-intervention variables that influenced selection: likely to be associ-
ated with the intervention (SQ2.2); OR likely to be influenced by the outcome or a cause of the outcome (SQ2.3)”. For analysis relying on post
hoc classification of intervention status, this may be difficult to assess but may be a critical source of bias. Also, for interventions that address
socio-economic determinants of health, it is highly likely that selection to receive the intervention will be on variables such as income or other mea-
sures of socio-economic deprivation, which is also a determinant of the outcome, health.
• Start of intervention coinciding with start of follow-up: clarification on how this should be assessed for studies where a baseline assessment of the
outcome was made before the participants received the intervention and then at follow-up after the intervention.
• Can SQ2.4 (Do start of follow-up and start of intervention coincide for most participants?) be applied to non-event type outcomes?
• Clarification of whether variation in lengths of exposure to the intervention at follow-up could contribute to selection bias.
Domain 4: deviation from intended interventions
Effect of interest
• Can analysis of post hoc classification of intervention status be interpreted as per protocol?
• Clarification of question “If your aim for this study is to assess the effect of initiating and adhering to the intervention (as in a per protocol analysis)”.
Does this relate to the aim for the review as agreed in the review protocol characteristics or the aim of the analysis used in the study being assessed?
Implementation and adherence
• Clarification about what is meant by successful implementation (SQ 4.4) and how authors should decide the level at which implementation
failure (SQ 4.4) and adherence (SQ4.5) is assessed (see Table 5).
• How should interventions which are tailored to individual need be assessed?
• Can it be assumed that there is no implementation failure where classification of intervention status is post hoc? By definition, all those in the
intervention group may be assessed to have received the intervention, but this will be dependent on the level at which the intervention is
being assessed (see Table 5).
Co-interventions
• Clarification about what constitutes a co-intervention (see Table 5).
• Clarification about when a co-intervention should be considered to be “important” (SQ4.3). Should there be an established association with the outcome?
Contamination and switching
• Clarification about the meaning when “contamination” constitutes “switching”, especially in cases where classification of intervention status is
post hoc. Guidance implies that contamination is inadvertent but this is difficult to determine in studies, see page 35 of ROBINS-I guidance.
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adherence (SQ4.2) should be assessed. Should this be
implementation of the programme, or delivery of the
intervention locally or use of or adherence to the inter-
vention by household? (Table 5) Or should it involve an
assessment at all levels? And how should interventions
which are tailored to individual need be assessed? Regardless
of what level is to be assessed, implementation difficulties
were almost impossible to assess due to lack of reporting. It
was also suggested that, where intervention classification is
post hoc, it may be assumed that there is no implementation
failure, as by definition, all those in the intervention group
have been assessed to have received the intervention.
There was uncertainty about what might constitute a co-
intervention and about when a co-intervention should be
considered to be “important” (SQ4.3). Reference to the defin-
ition of a co-intervention in the supplementary guidance (Ap-
pendix 1) enabled increased agreement between assessors.
Some uncertainty persisted, in particular, where studies fo-
cussed on the impacts of housing improvement delivered to
individual households as part of a broader programme of
neighbourhood improvements. In such cases, the additional
intervention(s) were part of the intended intervention, so may
not be a co-intervention, but the additional intervention may
be related to the outcome. For example, in one study, it was
reported that there were various additional renovations to
communal areas and changes in water and power supply de-
livered to some households. Although these changes may be
related to the health outcome of interest, the authors of that
study reported that these additional changes were not rele-
vant for changes in thermal comfort [12] (Table 5). Our group
of assessors was unclear whether this was a co-intervention
and whether it should be considered as “important. In an-
other study [13], the programme being delivered included
promotion of welfare uptake. Uptake of this part of the inter-
vention was greater in the comparison group, and household
income increased more in the comparison group than in the
intervention group. In most cases, it was not always known
what proportion, far less which individuals, had received the
additional intervention(s), and the additional intervention(s)
were sometimes available to the comparison group.
There was also lengthy discussion about when “contam-
ination” constituted “switching” and when it should be
considered as time varying confounding under Domain 1.
The confusion arose partly due to different interpretations
of the ROBINS-I guidance, as well as a lack of clarity about
the level at which the intervention was being assessed
(Table 5). In one study of a heating intervention which
used an ITT analysis, 7.2% of the intervention group did
not receive the intervention of interest during the study
period, despite being exposed to the programme of hous-
ing improvements, while 25.7% of the comparison group
had heating measures installed during the study period
[16]. This was assessed to be “contamination” by some but
not all. Further, there was unresolved discussion about the
Table 5 Differing interpretation about level of intervention being assessed and related implementation failure
Provided below are quotes from two included studies on study aim(s) and interventions
Braubach [12]*
Study aim: “to assess potential health impacts of improved thermal insulation. Key objectives were to assess the impact of thermal insulation
changes on indoor environments, and evaluate potential effects on residents’ health.”
Intervention description (may include possible co-interventions): “thermal insulation of all building facades; thermal insulation of the roof/ceiling of highest
dwelling; thermal insulation of basement/floor of lowest dwelling; installation of energy-efficient windows where replacements were necessary; installation of new
heating systems in buildings with substandard systems. Additional renovation projects without significance for thermal comfort were painting of staircases, instal-
lation of intercom systems, new power and water supply systems, improvement of outside spaces/greenery and other repairs as required. However, these renova-
tions are not part of the survey and their impact will not be looked at, although they may improve the general quality of the dwelling significantly.”
Shortt [13]*
Study aim: “The evaluation focussed on two elements of the process firstly, assessing the benefits to households in terms of indoor environment, health
and wellbeing and household income…. This paper focuses primarily on the installation of central heating in selected households and the immediate
effect on the dwellings and their occupants”
Intervention description (may include possible co-interventions): “installation of central heating systems and other energy efficiency measures in homes…The
overall aim was to develop an energy efficiency programme in partnership with key agencies and local communities and as a result to increase energy
awareness, increase uptake in grants and reduce the adverse effects on health and well-being caused by cold homes.” The intervention also involved
“encouraging higher uptake of social security benefits.”
*In both the above examples, the intervention was tailored according to the need of the individual household, but details of this was not reported
and was not controlled for in the analysis. In addition, subject to participants’ own resources, the interventions were available to participants
regardless of participation in the study, raising the potential for contamination. Again, this was not reported on.
Possible levels of implementation: potential for implementation failure/variation in adherence**
Programme level: selective uptake by eligible households or by external factors e.g. changes in funds available to those delivering intervention
Operational level: incomplete delivery or installation of intended intervention(s). Successful implementation may also require an educational
component to ensure recipients know how to use intervention effectively and have aspects such as potential benefits and costs explained.
Household level: householders in receipt of intervention do not use intervention as intended—heat more rooms but with same cost. Impacts are
dependent on behavioural change.
**External factors can also affect implementation and/or adherence such as changes in fuel costs.
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interpretation of “switching” where intervention and com-
parison groups were classified post hoc rather than at base-
line. Inadvertent changes in exposure to the intended
intervention or usual care may still occur where the inter-
vention classification is post hoc: However, this is not al-
ways assessed or known, especially where the intervention,
such as domestic heating measures, is widely available to
participants through other sources, rather than being re-
stricted as many clinical procedures and prescriptions are.
Domain 5: missing data
There was a high level of agreement for this domain with
all assessments being within one degree of each other. A
threshold for completeness of data is not provided by the
ROBINS-I guidance. It was suggested that an 80% thresh-
old may be useful for our studies given that the outcome of
interest was not rare, and attrition was unlikely to be re-
lated to our intervention of interest. There was discussion
about the extent of RoB due to attrition being related to
intervention effect size. If the effect on the outcome is
large, the effect of an identified RoB due to attrition may
be less important than on a small reported effect on the
outcome. For our intervention and outcome of interest,
none of the effects were expected to be large. This discus-
sion was not pursued to the point of defining “large” and
“small” effects as one of the ROBINS-I developers advised
us that small effects were not more susceptible to bias and
that the balance of missing data across groups was more
important for Domain 5. It was unclear how to assess the
balance across groups for an uncontrolled study.
Domain 6: measurement of outcomes
Assessments for all but one study were within one degree
of variation for Domain 6. The assessment for this domain
focusses on the use of objective outcomes and blinding of
assessors (SQ6.1 and 6.2). It was difficult to assess the
overall level of bias introduced in this domain, given that
self-reported outcomes were included as an outcome of
interest in the review protocol and the assessors agreed
that blinding to the intervention would not occur. In
addition, there were varying assessments of the subjectiv-
ity of different self-reported measures. For example, self-
report of a diagnosis of asthma may be considered to be
less subjective than self-reported wheeze.
Domain 7: selection of reported result
There was a high level of agreement for this domain with
all assessments being within one degree of each other. It
was agreed that where there was no protocol for the study,
the least severe assessment possible for SQs7.1 and 7.2
would be “Probably Yes”.
Overall assessment
The overall assessment for our studies varied, with most as-
sessments being “Critical” or “Serious” (Table 3). The overall
assessment for any single study cannot be less severe than
the most severe assessment allocated for a single domain for
that study. Domain 1 (confounding) was the highest (great-
est RoB) scoring domain, meaning that the overall assess-
ment largely reflected the level of confounding assessed.
There was greater agreement for the overall assessment than
for the individual domains; there was only one degree of dif-
ference in the overall assessment for 4/5 studies.
Assessing direction of bias
A question about the direction of bias is an option at
the end of each domain and the overall assessment.
However, the group of assessors agreed that it was not
possible to assess this as no clear rationale to support
these judgements was identified.
Comparison of ROBINS-I with EPHPP and Cochrane RoB tools
While there is some overlap across the tools, there are
also important differences in the bias domains assessed
(see Appendix 2). This limits the scope for a detailed
comparison across the three tools, and for this reason,
only the overall assessment for each study was compared
(Table 3). From this small group of studies, it would ap-
pear that ROBINS-I detected a higher RoB and may also
allow for greater nuance in the detection of bias com-
pared with the EPHPP tool. The Cochrane RoB assess-
ments were all “critical”, perhaps reflecting the absence
of randomisation, while there was variation in the
ROBINS-I assessments of bias across the studies.
Discussion
This work applied the ROBINS-I tool to a collection of
housing improvement studies. We aimed to assess
applicability and articulate the issues encountered when
applying ROBINS-I to a complex non-clinical interven-
tion delivered in a community or “usual care” setting,
particularly when applied to studies using a controlled
before and after (CBA) design. ROBINS-I helped to
systematically articulate sources of bias in NRS; however,
the lack of consensus in assessments raises questions
about its reliability. In particular, there may be useful
generalisations when interventions are assessed in
a“usual care” setting using a CBA design, and where the
EoI does not readily conform to ITT or per protocol.
Some of the difficulties with applying ROBINS-I to
CBAs of natural experiments may be resolved through
greater clarity in the guidance (see Table 4 for suggestions
based on our experiences) and provision of examples from
non-clinical interventions would help non-epidemiologist
researchers to grasp important concepts underpinning the
tool and the RoB domains. However, we identified more
fundamental difficulties related to the underpinning concepts
of ROBINS-I, which are discussed in more detail below.
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ROBINS-I for natural experiments: effect of interest (EoI),
post hoc classification of intervention status, and
appropriation of target trial
ROBINS-I assumes that the EoI being assessed in studies
under review will clearly be ITT or per protocol. When, as
in our experience, this is not straightforward, use of the
ROBINS-I tool is highly problematic. The EoI for the ori-
ginal review [11] was ITT. The review question was about
the effects of an intervention being delivered in a “usual”
care setting rather than efficacy. Therefore, our EoI was of
initiating an intervention or being allocated to an inter-
vention (ITT), rather than the effects of adhering to an
intervention (per protocol). Our group of studies appeared
to assess the effects of initiating an intervention in “usual
care” and the unit of analysis was an individual within the
household. However, ambiguity about the unit or level of
allocation of the intervention (Table 5) and the appropri-
ate level of assessment for implementation of and adher-
ence to the intervention, as well as lack of clarity about
the time of classification of intervention status, presented
difficulties when attempting to decide and agree an EoI,
either ITT or per protocol. The use of post hoc classifica-
tion of intervention status further complicated attempts to
agree the EoI as well as raising issues of selection and per-
formance bias. Our studies gathered data prospectively,
with no apparent selection of a sub-group for the main
analysis. Despite this, it is possible that individuals self-
selected into or out of the intervention group during the
study period for reasons that are linked to the intervention
and the outcome. This will be impossible to determine
when intervention status is classified post hoc and there-
fore introduces the possibility, albeit unknown, of critical
selection bias (Domain 2), as well as switching and time-
varying confounding (Domain 4).
The studies assessed fitted the definition of “pragmatic
trials”, assessing effects of an intervention in the “usual
care” setting [21]. Despite this, it could be argued that
these studies were not trials, neither pragmatic nor
explanatory. Consequently, these studies were not setting
out to establish effectiveness and the size of an effect;
rather, the purpose of these studies was to make use of
naturally occurring interventions, or natural experiments,
[22] to identify the existence, nature, and direction of
hypothesised health effects. These studies of natural
experiments are, therefore, at an earlier, more exploratory
stage, with different evidence priorities than is implicit in
the justification for a clinical trial, where evidence on basic
issues of safety and impacts on key outcomes is already
available. The exploratory and opportunistic nature of
these studies, together with a possible limited amount of
epidemiological or trial input to the study, may also
explain why key issues such as EoI, level and a clear defin-
ition of the intervention being assessed, timing of classifi-
cation of intervention status, and unit of assessment for
analysis are not always clearly articulated by study authors.
This raises important questions about the nature of ques-
tions being addressed by these studies, as well as the na-
ture of questions that evidence syntheses of data from
these more exploratory studies can address. This may also
have implications for the application of RoB assessments.
Applicability and usability of ROBINS-I for controlled before
and after studies of natural experiments
The difficulties in applying some of the concepts which
underpin the ROBINS-I tool to this group of studies, as
well as the poor levels of inter-rater reliability, raise ques-
tions about the applicability of ROBINS-I to assess RoB in
evaluations of natural experiments. To counter this, one
of the studies we assessed did perform an ITT analysis,
[16] suggesting that issues of post hoc classification and a
clear EoI should not be regarded as a defining characteris-
tic of CBAs of natural experiments. Moreover, issues of re-
liability are common in critical appraisal tools and are
certainly not unique to ROBINS-I [23–28]. Improvements
in reporting of intervention details [29, 30] as well as tim-
ing of classification of intervention status and EoI in pri-
mary studies could facilitate improved applicability of
ROBINS-I to CBA studies in public health, but this will
take years to be widely implemented. In the meantime,
there remains a need for a usable tool to assess RoB of
published evidence in CBAs of natural experiments and
which can take account of the issues outlined above.
ROBINS-I has been carefully developed and incorpo-
rates complex epidemiological concepts. Use of the tool
may require a level of epidemiological knowledge which is
beyond the capacity of many systematic review author
groups. Based on our own experience, where all assessors
had at least some experience in critical appraisal of NRS,
ROBINS-I was difficult to apply and not always helpful in
providing a sensitive assessment of RoB in CBA studies of
natural experiments. In addition, the investment needed
to apply ROBINS-I may be of questionable value when it
is known beforehand that there are important sources of
bias in the studies and when the data and subsequent
synthesis are not expected to produce conclusions with
high levels of certainty around a precise effect estimate. In
ROBINS-I, the overall RoB for a study is determined by
the highest level of bias in any single RoB domain. In our
small group of studies, the overall RoB was determined by
Domain 1 (confounding). One suggestion to improve effi-
ciency in applying ROBINS-I would be to conclude the as-
sessment when any domain is assessed as “Critical”.
However, others have raised questions about the appropri-
ateness of applying stringent RoB standards to natural
experiments. Specifically, suggesting that a RoB tool which
results in all evidence being labelled as “Critical” RoB may
hinder the development of evidence and knowledge for
many important topic areas, in particular within public
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health [31]. This, together with earlier questions about
comparing these studies to trials and determining ITT or
per protocol EoI, points to the need to explore the distinct
contribution of data from natural experiments and how
they may be used in subsequent evidence syntheses.
Conclusion
The ROBINS-I tool is a conceptually rigorous tool which
focusses on risk of bias due to the counterfactual and con-
sequently articulates limitations in the assessed studies
with respect to causal effect. Acknowledging these possible
sources of bias is critical and an issue which has not been
well addressed in previous critical appraisal tools. However,
currently, ROBINS-I is difficult to apply: ROBINS-I and its
guidance require further modification if it is to be applied
appropriately and reliably to studies assessing the effects of
natural experiments. The ROBINS-I developers are cur-
rently working to improve the applicability of the tool to
specific types of NRS, e.g. controlled before and after, inter-
rupted time series, and regression discontinuity designs.
We hope that the issues outlined in this paper, in particular
clarification about the appropriate EoI where the timing of
intervention classification is unclear or post hoc, will be
addressed in future versions of ROBINS-I.
Appendix 1
Supplementary guidance developed by authors to
facilitate consistent assessments
Domain 1: confounding
Confounders should be fitted into broad domains where
possible (see protocol level domains). Protocol level con-
founders should be considered as critical. Additional con-
founders should only be added where there is a grounded
justification to include this as an additional confounder, i.e.
not simple speculation that something may have happened.
Domain 2: selection of participants into the study
SQ2.1 “Was selection into the study (or into the analysis)
based on participant characteristics observed after the start
of the intervention?”: This does not mean selection of area
or household or individual for intervention or selection into
study. Rather, it means selection for analysis at end of study.
Alternative question “Was the sample in the final analysis
different to original study sample with respect to outcome
or exposure to the intervention (aside from attrition)?”
SQ2.4“Do start of follow-up and start of intervention coin-
cide for most participants?”: Criteria to define what is meant
by start of intervention and follow-up coinciding is not neces-
sary. This is about loss of important data before first follow-up.
Variation in length of exposure to intervention is not
part of selection bias.
None of the studies looked at prevalent exposure, rather,
they assess incident exposure. So all studies will be Y/PY for
SQs 2.1 and 2.2 (NB: this was not adhered to by assessors).
Note the overall assessment implies that 100% response
is required to be assessed as “low”; it is therefore unlikely/
impossible for any study to be assessed as “low” for this
domain. (NB: this was not adhered to by assessors).
Domain 3: classification of interventions
SQ3.2 “Was information used to define intervention
groups recorded at the start of the intervention?”: This re-
lates to misclassification of intervention status in analysis
and less about timing of recording intervention status.
SQ3.3 “Could classification of intervention status have
been affected by knowledge of the outcome or risk of
the outcome?”: This relates to those in the study sample.
Domain 4: deviation from intended interventions
Disruption is not a co-intervention; rather, disruption is
an essential part of the intervention. In ROBINS-I guid-
ance a co-intervention is “a new intervention that is not
part of intended intervention”, and “that individuals might
receive”, and “related to the intervention...and which are
prognostic for the outcome of interest”. Bear in mind that
questions assume potential for co-interventions to be bal-
anced across groups, and if not, this introduces bias.
For study specific target trial, all additional interventions
which were part of the intervention but where it was not
an essential part of the intervention should be listed, e.g.
where welfare advice or energy efficiency advice was also
offered but not always taken up.
SQ4.5 Switching includes contamination, though there
appears to be inconsistent advice in the guidance, see
p22 and p35 of guidance.
Domain 5: missing data
SQ5.1 “Were outcome data available for all, or nearly all, par-
ticipants?”: No threshold for completeness is provided. It may
be useful to have a threshold to improve transparency and
consistency of assessments. As none of the outcomes of inter-
est are rare and it is unlikely that attrition will be related to our
intervention of interest, an 80% threshold may be appropriate.
Balance of missing data across intervention and comparison
group is more important than taking effect size into account.
Domain 6: measurement of outcomes
No additional guidance
Domain 7: selection of reported result
SQ7.1 “Is the reported effect estimate unlikely to be
selected, on the basis of the results, from multiple
outcome measurements within the outcome domain?”and
Q7.2 “Is the reported effect estimate unlikely to be
selected, on the basis of the results, from multiple analyses
of the intervention-outcome relationship?” If no protocol
maximum assessment for both questions will be “Probably
Yes” (NB: this was not adhered to by assessors).
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Table 6 Comparison of Cochrane risk of bias (RoB) version 1.0, Effective Public Health Practice (EPHPP) tool, and ROBINS-I bias domains
assessed
Type of bias assessed Cochrane risk of bias (RoB) domains EPHPP tool domains ROBINS-I domains Comment
Selection Sequence generation (Cochrane RoB) Not applicable to NRS
Allocation concealment
(Cochrane RoB)
Study design (EPHPP) Domain 1: confounding
and Domain 2: selection
Confounding Baseline outcome characteristics
similar (EPOC)
Control for confounding
through analysis or design
(EPHPP)
Domain 1: confounding
Baseline characteristics similar (EPOC)
Baseline response Baseline response (EPHPP) Selection (EPHPP)
Attrition Incomplete outcome data
(Cochrane RoB)
Withdrawals at
follow-up (EPHPP)
Domain 5: missing data
Contamination* Contamination (EPOC)
Reporting* Selective reporting (Cochrane RoB) Domain 7: selection of
reported result
Performance * Blinding—participants
(Cochrane RoB)
Blinding—participants and
assessors (combined)
(EPHPP)
Domain 6: measurement
of outcome
Rarely applicable to
housing improvement
studies—no studies
blinded participantsDetection* Blinding—assessors (Cochrane RoB)
Blinding—analysts (EPHPP)
Performance* Intervention implementation:
within study variation of exposure
to intervention (review authors)
Heterogeneity of exposure
to intervention and
potential to benefit from
intervention (Review
authors)
Domain 3: measurement
of intervention
This measure used in
the Cochrane RoB and
EHPP was developed by
the authorsDomain 4: deviation
from intended
intervention
Outcome measure* Data collection (EPHPP) Designed to indicate
appropriate data
collection tools and
outcomes
Bracketed text indicates source of item: Cochrane RoB mandatory Cochrane RoB items; EPOC additional Cochrane risk of bias items recommended by the Effective
Practice and Organisation of Care (EPOC) group; EPHPP EPHPP tool recommended by Cochrane Public Health group
*Bias items NOT used in assessment of overall study quality for the original review of housing improvements due to lack of variation or application, e.g. no studies
were blinded
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